Thursday, March 14, 2019 10:18:54 AM
The agreements if you will, between USA/Russia/Ukraine/Japan are mutually accepted standards for clinical trials. Meaning, a clinical trial process in any one of the nearly 60 countries listed agree to accept each others findings, provided ALL the proper documentation is in order.
With Repurposed Drugs, they don't have to go back to the drawing board, because that same drug has already proven itself to be safe for Humans or Animals. Phase 1 of said process already has documented proof regarding the drugs Safety and Dosages.
Therefore, the drug now only has to prove it will work for another targeted purpose other than it's original intent. The Phase II and III trials does just that. Proves the drug works for something else.
It's not rocket science to understand that Drug Repurposing does not require certain levels of redundancy. The global agreements in place provides the scientific community a minimum level of cooperation so everyone isnt running around like a chicken with their head cut off.
Your method of thinking would create nothing but chaos versus uniformity- LAW & ORDER.
Bottom line goes back to the topline...you're not interested in facts. Just drama. Have at it mate. I'll keep doing what I have to do here. Which is offer folks something worth their time.
/////AMG
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM